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  1. Introduction
Amongnumerous commercial endeavors, nanotechnology is regarded as the key technology of the 21st century. It 
provides novel products and facilitates applications of innovative techniques in medicine, pharmacy, computer technology, 
and sensing. Therefore,  it  holds promise for potential  global socio-economic benefits.  In  2011, there were about 1100 
commercial products that include nanomaterials.The interesting physical property of graphene, a novel one-atom-thick two-
dimensional graphitic carbon system, has led to much excitement in recent yearsin material science and condensed-matter  
physics. Potential applications of graphene for nanoelectronics, sensors and nanocomposites have been actively pursued. 
The  biological  application  of  graphene  and  graphene  oxideremains  unexplored  andwide-open1.  There  are  several 
prerequisites for biological applications for a new material. First, rational functionalization chemistry is needed to impart  
graphene aqueous solubility and biocompatibility.  Graphene oxide and its chemically converted derivatives form stable 
suspensions in pure water but aggregate in salt or other biological solutions. Second, graphene sheets with suitable sizes are 
desired. Size control or size separation at various length scales is necessary to suitably interface with biological systems in 
vitro or in vivo. Graphene and graphene oxide samples thus far aretypically microns or larger in size. Lastly, little is known  
experimentally about the properties of graphene with molecular dimensions, on the order of ~10nm or below. The optical  
properties  of  graphene and  graphene oxide  are  largely unexplored,  a  topic  offundamental  interest  and  could facilitate  
biological and medical research such asimaging. It is a common belief that nanotechnology could assist in solving many 
Abstract
Graphene is a substance made of pure carbon, with atoms arranged in a regular 
hexagonal pattern similar  to graphite,  but in a one-atom thick sheet.  It  is  an allotrope of  
carbon whose structure is a single planar sheet of sp2-bonded carbon atoms that are densely 
packed in a honeycomb crystal lattice.Hence, graphene may be considered as the mother of 
graphite,  fullerene  and  carbon  nanotubes.  Graphene  can  also  be  considered  as  the  final  
member  of  the  series  of  fused  polycyclic  aromatic  hydrocarbons,  such  as  naphthalene, 
anthracene and coronene It has many exceptional featureswhich make it a superstar in the  
world of nanotechnology as thinnest material, practically transparent (3,000,000 sheets equal 
to 1mm), stiffest, strongest (Young’s modulus >0.5–1 TPa, tensile strength ~130 Gpa) largest 
surface-to-weight ratio (~2,700 m2/gram) very stretchable (stretch up to 20%), conducts heat  
and electricity better than any metal, impermeable to gases, large specific surface area, non-
toxic, low cost and drug can attach on both sides of its sheet. Graphene can be successfully 
used as a non-toxic nano carrier for efficient gene transfection, a novel gene delivery,nano-  
vector with low cytotoxicity and high transfection efficiency, which is promising for future  
applications in non-viral-based gene therapy. Experimental studies have demonstrated that the 
shape of carbonaceous nanomaterials plays an extremely important role in how they interact  
with  cells  and  potentially  other  biological  systems,  such  as  tissues  and  organisms.  The 
cytotoxicity of graphene depends on the exposure environment and mode of interaction with  
cells as bacteria came directly contactwith graphene, intensive physical interactions between 
graphene and bacterial cells may cause physical damages on cell membranes, and result in the 
release of intracellular contents and cytotoxicity and genotoxicity occur.
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global problems that society faces. These include environmental and health concerns of the fast-growing human population, 
as well as access to clean waterand affordable energy2. The quickly growing applications of nanomaterials are due to their 
unique properties which offer advantages over conventional materials. Since the 2010 Nobel awards validate the importance 
of graphene not only in basic research but also in various commercial applications .The demand for carbon nanostructures, 
particularly graphene,  is  increasing rapidly in  electrical,  mechanical,  and  biomedical  applications.  This  is  due to  their  
outstanding thermal, electrical, mechanical, optical and other unique properties3.
2. Graphene And Its Congeners
Graphene,  a 2D carbon nanomaterial  with a  honeycomb-like structure,  has  been the subject  of a  considerable  
interest  after  being the subject  of  the 2010 Nobel  Prize for  Physics.  Its  unique properties,  including ballistic  electron 
transport at room temperature,  tunable band-gap (for few-layer  graphene),  high chemical and mechanical  stability,  low 
electrical noise, high thermal conductivity, and bio compatibility, have led it to be used in many advanced devices ranging  
from ultra capacitors to spintronic devices. Although the intense interest and continuing experimental success of graphene-
based devices facilitate their various applications, the reliable production of high quality samples of graphene on a large 
scale is very difficult. At present, great efforts have been made toward the preparation of graphenenanosheets4. Grapheme is 
a single atomic plane of graphite (Gt), which was first obtained through micro mechanical exfoliation of Gt. Graphene oxide 
(GO) is a graphene sheet with carboxylic groups at itsedges and phenol hydroxyl and epoxide groups on its basal plane.  
Graphene oxide can be chemically exfoliated from graphite oxide (GtO). 
Thermal annealing or chemical treatment can eliminate functional groups on GO to produce reduced graphene 
oxide  (rGO).  Among them,  the  chemical  reduction  of  exfoliated  graphene  oxide  (EGO)  is  the  most  commonly used 
approach due to its  low cost  for large-scale production5.  In  the case of carbon nanotubes, closely related to graphene, 
controlling their  size and diameter  is  still  very challenging.  The availability of  carbon nanotubes,  both in  quality and  
quantity,  has stimulated the worldwide pursuit  of carbon nanotubes for technological  applications.  The morphology of 
graphene is different from that of carbon nanotube ; for example, the length of CNT influences their toxicity but graphene  
and graphene oxide (GO) do not have a ‘length’’ An important similarity between these carbon nano materials is that both 
graphene/graphene  oxide  and  carbon  nanotube  structures  vary  according  to  the  synthetic  processes  employed.  Such 
processes can also change their physical properties, including dispersity,  surface functionality,  and their toxicity.  In the  
materials science world, carbon nano structures such as fullerenes, carbon nano tubes and graphene are famous for their 
small dimension and unique architecture,  and several  possible applications in diversified areas.  These graphene related 
materials exhibit unique electronic, thermal, and mechanical properties,and hold great promises in potential applications, 
such as nanoelectronics, conductive thin films, supercapacitors, nanosensors and nanomedicine. To realize their potentials, 
health and environmenta limpacts of graphene related materials should be thoroughly evaluated6.
2.1 Nanotoxicity Of Carbon Allotrope Graphene
Compared to other synthetic carbon nanomaterials, such as fullerenes and carbon nanotubes,  it was reported that 
GO and rGO exhibit strong antibacterial activity. The antibacterial activity of GO and rGO has been attributed to membrane  
stress induced by sharp edges of grapheme nanosheets, which may result in physical damages on cell membranes, leading to 
the loss of bacterial membrane integrity and the leakage of RNA. On the other hand, it was proposed that graphene may 
induce oxidative stress on neural phaeochromocytoma derived cell. The antimicrobial activity of graphene has been found 
to be the  synergy of  both “physical”  and  “chemical”  effects.  When bacteria  directly contact  with graphene,  intensive  
physical interactions between graphene and bacterial cells may cause physical damages on cell membranes, and result in the  
release of intracellular contents. Grapheme may chemically increase cellular oxidative stress, which could disrupt a specific  
microbial process. If graphene- based materials share a similar antibacterial mechanism as that of material characteristics 
which influence how graphene-based materials physically interact with bacterial cells, such as solubility,dispersion, and  
size, should strongly influence their antibacterial activities. Moreover, material properties,which control their abilities in 
producing cellular oxidative stress, should also have a strong impact on their antibacterial activities7.
The diagnostic and therapeutic applications of graphen ebased materials mentioned above will  only be trialed 
clinically after detailed information on their environmental and health and safety effects in host biological systems. A few 
preliminary tests have showed that  graphene are biologically benign to certain cells,  tissues,  and organs under limited 
conditions, while further studies have indicated that graphene are potential hazards that can cause both acute and chronic 
adverse effects to many living systems. Nevertheless, at this stage, it appears that the biological effects of graphene are  
sample specific and must be assessed on a case-by-case basis. The nanotoxicity of graphene, therefore, requires continuing 
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and extensive investigations and, indeed, this will be required by regulatory bodies before graphene can be used in clinical  
environments as functional  biomaterials and biomedical devices8.  Despite several  years of research, definitive findings 
regarding the extent of toxicological  risks arising from using nanotubes are far from complete.  Continuing research is  
required  to  determine,  for  example,  how graphene  enter  cells,  where  graphene  are  internalized,  which  the  cytotoxic  
mechanisms are relevant, and how the nanotoxicity is affected by a variety of physicochemical characteristics, such as 
diameter, length, and presence of impurities, surface functionalization, and surface wettability9.
2.2 Mechanism Of Cellular Uptake Of Graphene
The uptake of graphene into cells plays a critical  role in determining their cytotoxicity and genotoxicity.  The  
outermost  layer  of  the  cell,  the  cellular  membrane,  consists  of  a  phospholipid  bilayer,  which  serves  to  segregate  the  
subcellular compartments from the external medium, and to regular the transport of foreign materials, including graphene 
into  cells.  Experimental  results  indicate  that  graphene  can  be  internalized  by a  variety  of  cells.  Although  systematic 
knowledge is still lacking, it is in general considered that there are two possible pathways for graphene to cross the cellular  
membrane and enter cells. One pathway is passive transport,which includes diffusion, membrane fusion, and direct pore 
transport. Individually dispersed graphene in aqueous solutions have been experimentally demonstrated to be able to enter 
the cytoplasm of cells by directly crossing the membrane, despite recent modeling showing that the energy cost of entering  
the cellular membrane via rupture and diffusion was high compared to that of the energy of thermal motion of graphene.A 
more common pathway for the cellular uptake of graphene is active transport via endocytosis, which includes phagocytosis 
and pinocytosis. Endocytosis involves the enclosing of foreign objects in vesicles orvacuoles pinched off from the cellular 
membrane. 
In  general,  long graphene (>1  μm in length)  were taken up by phagocytosis,which was mainly conducted by 
macrophages, monocytes, and neutrophils. Shorter graphene of length from a few to several hundred nanometers, on the 
other  hand,  were  mainly  internalized  by  pinocytosis,  such  as  macropinocytosis,  clathrin-mediated  endocytosis,  and 
caveolin-driven endocytosis.  Endocytosis is  an energy-dependent  process,and the orientation of  graphene entry can be  
controlled bythe interplay between the tip recognition through receptorbinding and the rotation driven by asymmetric elastic  
strain at the nanotube-phospholipid bilayer interface, as demonstrated recently by numerical modeling. Inthe most common 
case, a near-perpendicular orientation resulted in a minimum energy barrier. The exact cellular uptake pathway of graphene  
is complex and depends on many experimental parameters, such as the size, length, hydrophobicity, surface chemistry, and 
the cell culture medium. Additionally, the hydrophobic surface of graphene can interact with components in cell growth  
medium and affect the cellular uptake. Serum proteins in the cell growth medium can bind to graphene walls through π-π 
interactions or electrostatic attractions, forming a protein coating. The “screening effect” of such protein coatings, known as 
the “protein corona,” allows functionalized graphene to experience a similar cellular uptake pathway. The cytotoxic effect of 
size and shape of graphene is best represented by their high aspect ratio, which results in incomplete phagocytosis by the 
mononuclear cells because the graphene are too large. This induced incomplete or frustrated phagocytosis can result in  
macrophage activation and granulomatous inflammation10.  In fact,  it  has been hypothesized that the failure of resident 
macrophages to clear graphene is the main reason for the activation of pro inflammatory pathways that induce lung fibrosis,  
lung cancer, and malignant mesothelioma. In addition, the aggregation of graphene by van der Waals’ interactions could also 
affect profibrogenic cellular responses and contribute to the pulmonary toxicity of graphene in vivo11.
The cytotoxicity level of graphene to that of carbon nanotubes founded that toxicity was shape and composition 
dependent, with graphene overall having a lower toxicity than CNTs; however the toxicity of graphene was curiously found 
to be inverse to concentration, with graphene exhibiting a higher toxicity than CNTs at low concentrations12. However, 
sharp graphene nanosheet edges have been shown to cause considerable damage to the cell membrane of bacteria,although  
this antibacterial property has the potential tobe useful. Moreover, hydrophilic carboxyl-functionalized graphenes have been 
shown to be able to be internalized incells without any toxic effects, in contrast to hydrophobic pristine graphene. 
2.3 Biodistribution And Nanotoxicity Of Graphene In Other Organs
Many in vivo  studies have shown that graphene delivered to a specific area in the body are not confined to that 
area. For example, intravenously injected graphene were shown to be taken up both by the liver and the spleen and then  
excreted rapidly through the kidney. Because of the migration of graphene in biological systems,their toxicity to a variety of 
other  organs should also be tested.  In  many cases,  macrophages,  which form the first  line of  defense against  foreign  
materials, will interact with the administrated grapheme 13. This is why macrophages are one of the mostly studied cells in 
in vitro investigations of graphene toxicity. After graphene have been ingested by macrophages,they can enter into the blood 
and lymph circulation at alater stage. Carbon nanotubes can also be dispersed by mucins (glycosylated proteins produced by 
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epithelial tissues)in certain cases and cleaned away in a physiological solution,before they can interact with cells14.
3. Future Prospects
As mentioned above for any biological-related application, particularly  in vivo  applications, great care must be 
taken to ensure that the toxicity of the nanomaterial is well characterized and understood. There are many challenges ahead  
that  must be addressed before graphene and its derivatives can be successfully integrated into biomedical devices and  
technology.  The main advances required advanced techniques and facile  methods increase the sensitivity of  grapheme 
biosensors towards single-molecule detection followed by more efficient loading and unloading methods for drug delivery 
would refine overall performance of carbon allotropeas carriers. Further research is required into various carbon allotropes  
to  promote  cell  adhesion,  growth,  differentiation,and  proliferation.  The  novel  graphitic  nanostructures,  combined  with 
multi-functionalities  including  biocompatibility,  photoluminescence  and  drug  loading  and  delivery,  suggest  promising 
applications of graphene materials in biological and medical areas.
4. Conclusion
Having unique  mechanical,  electrical,  optical,  and  thermal  properties,  graphene and its  congeners  show great 
promise  for  advancing  the  fields  of  biology  and  medicine.  Many  reports  have  demonstrated  that  of  these  carbon  
nanostructures and their hybrid structures (composites with polymers, ceramics, and metal nanoparticles) for a variety of  
biomedical  areas  ranging from biosensing,  drug delivery,  and diagnostics,  to cancer  treatment,  tissue engineering,  and 
bioterrorism prevention. However, the issue of the safety and toxicity of these carbon nanostructures, which is vital to their  
use as diagnostic and therapeutic tools in biomedical fields, has not been completely resolved.  Nanoscalegraphene and 
graphene oxide have immense potential in nanomedicine as biocompatible and supportive substrates, and as a novel tool for 
the delivery of therapeutic molecules. Graphene can be successfully used as a non-toxic nano-vehicle for efficient gene  
transfection, a novel gene delivery nano- vector with low cytotoxicity and high transfection efficiency, which is promising 
for future applications in non-viral-based gene therapy.
Acknowledgement
I  would like to acknowledge Dr.  HimanshuPandey(Department  of  Pharmaceutical  Sciences,  Faculty of  Health 
Sciences, SHIATS, Allahabad, UP for his valuable information and technical assistance.
References
1. Jain S, Singh SR, Pillai S Toxicity Issues Related to Biomedical Applications of Carbon Nanotubes, J Nanomed Nanotechol 2012, 
3(5): 140-155.
2. Yi Wang et al., Controlled drug release characteristics and enhanced antibacterial effect of graphene oxide/drug intercalated layered 
double hydroxides hybrid films , J. Mater. Chem., 2012. (online)
3. Tapan Kumar Das,  et al., Graphene: A Revolution in Nanobiotechnology,  Journal of Research in Nanobiotechnology (2012) 1(1): 
019-030.
4. Zhuang Liu,  et al., PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer Drugs,  J. Am. Chem. Soc. 2008,  130: 
10876–10877.
5. Shaobin  Liu,  et  al.,  Lateral  Dimension-Dependent  Antibacterial  Activity  of  Graphene  Oxide  Sheets,  Langmuir 2012,  28: 
12364−12372.
6. Santos Catherine M , Mangadlao Joey,  et al., Graphenenanocomposite for biomedical applications: fabrication, antimicrobial and 
cytotoxic investigations, Nanotechnology, 2012, (online)
7. Caitlin Fisher,  et al., Applications and Nanotoxicity of Carbon Nanotubes and Graphene in Biomedicine,  J. Nanomaterials, 2012, 
(online)
8. Mei Yang , Jun Yao et al., Graphene and its derivatives for cell biotechnology, Analyst , 2012, (online)
9. Sivasankar, M.,BogaPramod Kumar, Role of Nanoparticles in Drug Delivery System,  Int. J. of Res. Phar. and Bio. Sci. 2010, 1 (2): 
41-67.
10. Lovelyn, C., Attama, A., Current State of Nanoemulsions in Drug Delivery, J. of Bio. and Nanobiotech. 2011, 2: 626-639.
11. Jiraporn C.,Nanosuspension Technology for Drug Delivery, Walailak J Sci & Tech 2007; 4(2): 139-153.
12. Sailaja, A.K, Amareshwar, P, Chakravarty, P,Chitosan nanoparticles as a drug delivery system, Res. J. of Phar., Bio.and Chem. Sci. 
2010, 1(3): 474-485.
13. Ochekpe, N.A, Patrick O,Ngwuluka, C., Nanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery,  Tro. J. of  
Phar. Res. 2009; 8 (3): 275-287.
14. Mohanraj V.J., Chen. Y., Nanoparticles – A Review. Tro. J. of Phar. Res. June 2006; 5 (1): 561-573.
